01 1Chongqing Huapont Pharmaceutical
01 1ROFLUMILAST
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-01-21
Pay. Date : 2014-09-10
DMF Number : 28506
Submission : 2014-07-22
Status : Active
Type : II
20
Chongqing Huapont Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ROFLUMILAST, with a corresponding US DMF Number 28506.
Remarkably, this DMF maintains an Active status since its submission on July 22, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 21, 2015, and payment made on September 10, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
